A Non-Profit Approach to Address Foreign Dependence of Generic Drugs

Dan Liljenquist, Ge Bai, Ameet Sarpatwari, Gerard F. Anderson

Research output: Contribution to journalArticlepeer-review

Abstract

The COVID-19 pandemic has revealed the vulnerability of the US generic drug supply chain to foreign production. Many policies have been proposed to mitigate this vulnerability. In this article, we argue that nonprofit drug manufacturers have the potential to make important contributions.

Original languageEnglish (US)
Pages (from-to)30-33
Number of pages4
JournalThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Volume49
Issue number1
DOIs
StatePublished - 2021

Keywords

  • Drug Supply Chain
  • Foreign Dependence
  • Generic Drug
  • Non-profit
  • Prescription Drug Manufacturing

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health Policy

Fingerprint

Dive into the research topics of 'A Non-Profit Approach to Address Foreign Dependence of Generic Drugs'. Together they form a unique fingerprint.

Cite this